LEADER 01029nam0 2200313 4500 001 000029997 005 20140410185721.0 010 $a978-88-08-17114-6 100 $a20140410d2013----km-y0itay50------ba 101 1 $aita 102 $aIT 105 $ay-------001yy 200 1 $aBiologia della conservazione$fRichard B. Primack, Luigi Boitani 205 $a2. ed. italiana 210 $aBologna$cZanichelli$d2013 215 $aXI, 403 p.$cill.$d27 cm 300 $aSul frontespizio: Con sito web. 312 $a5. ed., 2012 500 10$a<>primer of conservation biology$m<>$940663 610 1 $aBiodiversità$aProtezione 610 1 $aEcologia 676 $a333.9516$v21$9Risorse biologiche. Conservazione e Tutela 700 1$aPrimack,$bRichard B.$4070$0293344 701 1$aBoitani,$bLuigi$4070$074217 801 0$aIT$bUNIPARTHENOPE$c20140410$gRICA$2UNIMARC 912 $a000029997 951 $aP1 333-B/3$b45017$cPIST$d2014 996 $aPrimer of conservation biology$940663 997 $aUNIPARTHENOPE LEADER 05309nam 2200637 a 450 001 9910141369203321 005 20170815161644.0 010 $a1-118-44497-3 010 $a1-118-99709-3 010 $a1-283-80395-X 010 $a1-118-44489-2 035 $a(CKB)2670000000276785 035 $a(EBL)1061888 035 $a(OCoLC)818819716 035 $a(SSID)ssj0000754614 035 $a(PQKBManifestationID)12278999 035 $a(PQKBTitleCode)TC0000754614 035 $a(PQKBWorkID)10726290 035 $a(PQKB)11136718 035 $a(MiAaPQ)EBC1061888 035 $a(EXLCZ)992670000000276785 100 $a20120405d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical endocrinology of companion animals$b[electronic resource] /$fedited by Jacquie Rand 210 $aAmes, Iowa $cWiley-Blackwell$d2013 215 $a1 online resource (538 p.) 300 $aDescription based upon print version of record. 311 $a0-8138-0583-X 320 $aIncludes bibliographical references and index. 320 $aIncludes bibliographical references and index. 327 $aClinical Endocrinology of Companion Animals; Copyright; Contents; Contributors; Preface; 1 Hypoadrenocorticism in Dogs; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 2 Hypoadrenocorticism in Cats; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnosis; VI. Treatment; VII. Prognosis; VIII. Prevention; 3 Hypoadrenocorticism in Other Species; Hypoadrenocorticism in Horses; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis 327 $aV. Differential DiagnosisVI. Treatment; VII. Prognosis; VIII. Prevention; Hypoadrenocorticism in Ferrets; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnosis; VI. Treatment; VII. Prognosis; VIII. Prevention; Hypoadrenocorticism in Pet Birds; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnosis; VI. Treatment; VII. Prognosis; VIII. Prevention; 4 Critical Illness-Related Corticosteroid Insufficiency (Previously Known as Relative Adrenal Insufficiency); I. Pathogenesis; II. Signalment; III. Clinical Signs 327 $aIV. DiagnosisV. Differential Diagnosis; VI. Treatment; VII. Prognosis; VIII. Prevention; 5 Hyperadrenocorticism in Dogs; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 6 Primary Functioning Adrenal Tumors Producing Signs Similar to Hyperadrenocorticism Including Atypical Syndromes in Dogs; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnosis; VI. Treatment; VII. Prognosis; VIII. Prevention; 7 Hyperadrenocorticism in Cats; I. Pathogenesis; II. Signalment 327 $aIII. Clinical SignsIV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 8 Primary Functioning Adrenal Tumors Producing Signs Similar to Hyperadrenocorticism Including Atypical Syndromes in Cats; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 9 Hyperadrenocorticism in Ferrets; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention 327 $a10 Hyperadrenocorticism and Primary Functioning Adrenal Tumors in Other Species (Excluding Horses and Ferrets)I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 11 Hyperadrenocorticism (Pituitary Pars Intermedia Dysfunction) in Horses; I. Pathogenesis; II. Signalment; III. Clinical Signs; IV. Diagnosis; V. Differential Diagnoses; VI. Treatment; VII. Prognosis; VIII. Prevention; 12 Primary Hyperaldosteronism; Hyperaldosteronism; I. Pathogenesis; II. Signalment; III. Clinical Signs 327 $aIV. Diagnosis-Laboratory Assessment and Diagnostic Imaging 330 $a Clinical Endocrinology of Companion Animals offers fast access to clinically relevant information on managing the patient with endocrine disease. Written by leading experts in veterinary endocrinology, each chapter takes the same structure to aid in the rapid retrieval of information, offering information on pathogenesis, signalment, clinical signs, diagnosis, differential diagnosis, treatment, prognosis, and prevention for a broad list of endocrine disorders. Chapters begin with brief summaries for quick reference, then delve into greater detail. With complete coverage of the 606 $aVeterinary endocrinology 606 $aPets$xDiseases 608 $aElectronic books. 615 0$aVeterinary endocrinology. 615 0$aPets$xDiseases. 676 $a636.089/64 676 $a636.08964 701 $aRand$b Jacquie$0946287 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910141369203321 996 $aClinical endocrinology of companion animals$92137927 997 $aUNINA